| AJCC | American Joint Committee on Cancer |
| BAP1 | BRCA1 associated protein 1 |
| BCL2 | B-cell lymphoma 2 |
| BCL2A1 | BCL2 related protein A1 |
| BCL2L1 | BCL2 like 1 |
| BCLxL | B-cell lymphoma-extra large |
| BPS | Branchpoint sequence |
| BRD9 | Bromodomain containing 9 |
| BUD31 | BUD31 homolog |
| CLL | Chronic Lymphocytic Leukemia |
| CSV | Chromosomal structural variants |
| CYSLTR2 | Cysteinyl Leukotriene Receptor 2 |
| DDX46 | DEAD-Box Helicase 46 |
| DNA-PK | DNA-dependent protein kinase |
| EIF1AX | Eukaryotic Translation Initiation Factor 1A X-Linked |
| EOE | Extraocular tumor extension |
| ESE | Exonic splicing enhancer |
| FAG | Fluorescein Angiography |
| GNAQ | G protein Subunit Alpha Q |
| GNA11 | G protein Subunit Alpha 11 |
| GPCR | G protein-coupled receptors |
| HEAT | Huntington, Elongation factor 3, protein phosphatase 2A, targets of rapamycin 1 |
| HR | Homology recombination |
| K | Lysine |
| M3G8q | Monosomy 3, gain of 8q |
| MCL1 | MCL1 apoptosis regulator |
| MDS | Myelodysplastic syndromes |
| MUT | Mutated |
| MYC | MYC proto-oncogene, BHLH transcription factor |
| ncBAF | Non-canonical BAF |
| NHEJ | Non-homologous end joining |
| NMD | Nonsense mediated decay |
| PLCB4 | Phospholipase C Beta 4 |
| PRMT5 | Protein Arginine Methyltransferase 5 |
| Py | Polypyrimidine |
| R | Arginine |
| RARS | Refractory anemia with ring sideroblasts |
| SF3B1 | Splicing Factor 3b Subunit 1 |
| SRSF2 | Serine- and arginine-rich splicing factor 2 |
| snRNP | Small nuclear ribonucleoprotein particles |
| TERT | Telomerase reverse transcriptase |
| TNM | Tumor-node-metastasis |
| U2AF | U2 small nuclear RNA auxiliary factor |
| U2AF2 | U2 small nuclear RNA auxiliary factor 2 |
| UM | Uveal melanoma |
| US | Ultrasonography |
| WT | Wild type |